ciprofloxacin has been researched along with Pyrexia in 130 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess the effectiveness of the adjunction of a one-gram single dose of ciprofloxacin to a symptomatic treatment for the early treatment of uncomplicated diarrhea during military operations of the French service members in Africa." | 9.69 | A single dose of ciprofloxacin reduces the duration of diarrhea among service members deployed in Africa. ( Aigle, L; Coton, T; Desplans, J; Le Dault, E; Marimoutou, C; Mayet, A; Savini, H; Sicard, S; Simon, F, 2023) |
| "We aimed to determine the noninferiority of fosfomycin compared to ciprofloxacin as an oral step-down treatment for Escherichia coli febrile urinary tract infections (fUTIs) in women." | 9.51 | Fosfomycin Vs Ciprofloxacin as Oral Step-Down Treatment for Escherichia coli Febrile Urinary Tract Infections in Women: A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial. ( Bonten, MJM; Branger, J; Geerlings, SE; Hassing, RJ; Hoepelman, AIM; Ketels, T; Koldewijn, EL; Koster, A; Kuiper, S; Ten Doesschate, T; van den Bijllaardt, W; van der Bij, AK; van Mens, SP; van Nieuwkoop, C; van Werkhoven, CH, 2022) |
| "Fluoroquinolones reduce occurrence of fever in adult cancer patients who develop neutropenia, but there has been no randomized controlled trial in children, and there are only a few studies considering resistance in intestinal floral after ciprofloxacin has been used." | 9.17 | Ciprofloxacin reduces occurrence of fever in children with acute leukemia who develop neutropenia during chemotherapy. ( Chelae, S; Khwanna, T; Laoprasopwattana, K; Sujjanunt, T; Suwankeeree, P; Tunyapanit, W, 2013) |
| " The present study was designed to evaluate the benefit of intravenous ciprofloxacin for neutropenic patients with fever who were refractory to initial therapy given for the first 3 days." | 9.12 | Efficacy of intravenous ciprofloxacin in patients with febrile neutropenia refractory to initial therapy. ( Kawano, F; Koga, S; Matsuoka, H; Okamura, S; Shibata, K; Shirahashi, A; Suzushima, H; Tamura, K; Tsukamoto, A; Uozumi, K; Yamashita, K, 2006) |
| "In a prospective randomized trial, 40 stage IV breast cancer patients undergoing intermediate high-dose chemotherapy (cyclophosphamide, 5-fluorouracil plus epirubicin or methotrexate), received either recombinant human G-CSF (rhG-CSF, group I) or ciprofloxacin and amphotericin B (CAB, group II) for prevention of febrile leucopenia (FL)." | 9.09 | Prevention of febrile leucopenia after chemotherapy in high-risk breast cancer patients: no significant difference between granulocyte-colony stimulating growth factor or ciprofloxacin plus amphotericin B. ( de Vries, EG; Hospers, GA; Mulder, NH; Schröder, CP; Sleijfer, DT; van der Graaf, WT; Willemse, PH, 1999) |
| "The objective of this study was to test the efficacy of oral ciprofloxacin in the treatment of lower risk febrile neutropenia (LRFN) in children treated for malignant diseases." | 9.09 | Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia. ( Armada, A; Cáceres, E; Casimir, L; Debbag, R; Fernández, C; Firpo, V; Latella, A; Paganini, H; Rodriguez-Brieshcke, T; Zubizarreta, P, 2001) |
| "This intervention influenced administration of ciprofloxacin without apparent compromise of patient outcomes and resulted in a reduction in total costs of treating febrile neutropenia." | 9.09 | A new ciprofloxacin stepdown program in the treatment of high-risk febrile neutropenia: a clinical and economic analysis. ( de Lemos, ML; Frighetto, L; Jewesson, PJ; Marra, CA; Marra, F; Quaia, CB; Warkentin, DI, 2000) |
| "Low-risk patients (N = 70) with episodes of fever and neutropenia (N = 116) were randomized to receive either oral ciprofloxacin or intravenous ceftriaxone as outpatients." | 9.09 | Oral ciprofloxacin vs. intravenous ceftriaxone administered in an outpatient setting for fever and neutropenia in low-risk pediatric oncology patients: randomized prospective trial. ( Campos, MC; Dantas, LS; Ginani, VC; Petrilli, AS; Seber, A; Tanaka, C, 2000) |
| " The use of monotherapy with intravenous ciprofloxacin (200 to 300 mg every 12 h) was evaluated against combined therapy with piperacillin plus amikacin in febrile granulocytopenic patients with solid tumor or lymphoma." | 9.07 | Prospective randomized evaluation of ciprofloxacin versus piperacillin plus amikacin for empiric antibiotic therapy of febrile granulocytopenic cancer patients with lymphomas and solid tumors. The European Organization for Research on Treatment of Cancer ( Calandra, T; Gaya, H; Glauser, M; Klastersky, J; Meunier, F; Viscoli, C; Zinner, SH, 1991) |
| "In a double-blind, randomized, placebo-controlled trial 50 adult patients with acute diarrhea received either 500 mg ciprofloxacin b." | 9.06 | Ciprofloxacin in the treatment of acute bacterial diarrhea: a double blind study. ( Diridl, G; Pichler, H; Wolf, D, 1986) |
| "We compared the combination of teicoplanin plus ciprofloxacin with gentamicin plus piperacillin for the empirical treatment of fever in 80 neutropenic patients." | 9.06 | A randomized study of teicoplanin plus ciprofloxacin versus gentamicin plus piperacillin for the empirical treatment of fever in neutropenic patients. ( Collins, PW; Delord, C; Kelsey, SM; Newland, AC; Weinhard, B, 1990) |
| "We examined the efficacy of ciprofloxacin as an empirical treatment for fever in 97 neutropenic patients in a randomized study of ciprofloxacin and benzylpenicillin versus netilmicin and piperacillin." | 9.06 | A comparative study of intravenous ciprofloxacin and benzylpenicillin versus netilmicin and piperacillin for the empirical treatment of fever in neutropenic patients. ( Jenkins, GC; Kelsey, SM; Newland, AC; Shaw, E; Wood, ME, 1990) |
| "To assess the efficacy of ciprofloxacin in neutropenic patients, we conducted a randomized prospective trial comparing the combination of ciprofloxacin and netilmicin against piperacillin plus netilmicin as an empiric treatment of fever in cancer patients with neutropenia." | 9.06 | Randomized trial comparing ciprofloxacin plus netilmicin versus piperacillin plus netilmicin for empiric treatment of fever in neutropenic patients. ( Anderson, H; Chan, CC; Oppenheim, BA; Scarffe, JH; Swindell, R, 1989) |
| "This study developed further clinical experience in using a single agent ("monotherapy") as empirical treatment for neutropenic patients with fever, and compared the safety and toxicity of two candidate agents, ceftazidime and ciprofloxacin." | 9.06 | A prospective, randomized comparison of ceftazidime and ciprofloxacin as initial empiric therapy in neutropenic patients with fever. ( Bayston, KF; Cohen, J; Want, S, 1989) |
| "To compare the effectiveness and toxicity of ciprofloxacin vs an aminoglycoside, both in combination with a beta-lactam, for the treatment of febrile neutropenia in the inpatient setting." | 8.82 | Ciprofloxacin vs an aminoglycoside in combination with a beta-lactam for the treatment of febrile neutropenia: a meta-analysis of randomized controlled trials. ( Bliziotis, IA; Christodoulou, C; Chrysanthopoulou, S; Falagas, ME; Kasiakou, SK; Michalopoulos, A; Samonis, G, 2005) |
| "In this retrospective study, we analyzed the clinical data and outcome of patients with AML who did or did not receive prophylactic ciprofloxacin 500 mg BD for neutropenic fever." | 7.83 | Prophylaxis of neutropenic fever with ciprofloxacin in patients with acute myeloid leukemia treated with intensive chemotherapy. ( Foratyazdi, M; Ghadiany, M; Mehdizadeh, M; Mohammad Alizadeh, A; Rahimi, H; Rezvani, H; Zamani, N, 2016) |
| "The objective of this investigation was to assess retrospectively the safety and the efficacy of oral ciprofloxacin plus cefuroxime axetil compared to the combination of oral ciprofloxacin plus amoxicillin/clavulanate, as initial outpatient treatment, in low-risk cancer patients with fever and neutropenia." | 7.74 | Comparison of two oral regimens for the outpatient treatment of low-risk cancer patients with chemotherapy-induced neutropenia and fever: ciprofloxacin plus cefuroxime axetil versus ciprofloxacin plus amoxicillin/clavulanate. ( Karabelis, A; Kordossis, T; Kosmas, C; Sipsas, NV; Skopelitis, E; Tsavaris, N; Vadiaka, M; Ziakas, PD, 2007) |
| "The influence of fever on the pharmacokinetics of ciprofloxacin was investigated in seven patients with acute febrile diseases." | 7.70 | Influence of fever on the pharmacokinetics of ciprofloxacin. ( Belic, A; Beovic, B; Grabnar, I; Karba, R; Marolt-Gomiscek, M; Mrhar, A; Zupancic, T, 1999) |
| "To assess the value of prophylactic ciprofloxacin in reducing the incidence of neutropenic fever in men receiving intensive chemotherapy for germ cell tumours, we reviewed the case notes of 88 consecutive patients treated between January 1986 and December 1992." | 7.69 | Chemotherapy for germ cell tumours: prophylactic ciprofloxacin reduces the incidence of neutropenic fever. ( Counsell, R; Pratt, J; Williams, MV, 1994) |
| "We studied the efficacy of piperacillin and ciprofloxacin as initial parenteral therapy in 41 adult patients with leukemia who developed 47 febrile episodes during severe neutropenia following chemotherapy." | 7.68 | A pilot study of piperacillin and ciprofloxacin as initial therapy for fever in severely neutropenic leukemia patients. ( Lerner, R; Nilsson, PG; Palmblad, J; Samuelsson, J; Wahlin, A; Winqvist, I, 1992) |
| "Inclusion criteria were cancer, febrile neutropenia, low risk of complications as predicted by a Multinational Association for Supportive Care in Cancer (MASCC) score > 20, ability to swallow, and ≤ one single intravenous dose of empiric antibiotic therapy before study drug treatment initiation." | 6.78 | Oral antibiotics for fever in low-risk neutropenic patients with cancer: a double-blind, randomized, multicenter trial comparing single daily moxifloxacin with twice daily ciprofloxacin plus amoxicillin/clavulanic acid combination therapy--EORTC infectiou ( Akan, H; Akova, M; Aoun, M; Calandra, T; de Bock, R; Drgona, L; Kern, WV; Marchetti, O; Paesmans, M; Viscoli, C, 2013) |
| "Pediatric cancer patients presenting with febrile neutropenia after non-myeloablative chemotherapy and who met institutional criteria for early hospital discharge following a minimum of 48-hr inpatient empiric intravenous ceftazidime were eligible for the study." | 6.71 | Ciprofloxacin and amoxicillin as continuation treatment of febrile neutropenia in pediatric cancer patients. ( Burns, JL; Coughlin, J; Friedman, DL; Hawkins, D; Park, JR; Pendergrass, T, 2003) |
| "To assess the effectiveness of the adjunction of a one-gram single dose of ciprofloxacin to a symptomatic treatment for the early treatment of uncomplicated diarrhea during military operations of the French service members in Africa." | 5.69 | A single dose of ciprofloxacin reduces the duration of diarrhea among service members deployed in Africa. ( Aigle, L; Coton, T; Desplans, J; Le Dault, E; Marimoutou, C; Mayet, A; Savini, H; Sicard, S; Simon, F, 2023) |
| "We aimed to determine the noninferiority of fosfomycin compared to ciprofloxacin as an oral step-down treatment for Escherichia coli febrile urinary tract infections (fUTIs) in women." | 5.51 | Fosfomycin Vs Ciprofloxacin as Oral Step-Down Treatment for Escherichia coli Febrile Urinary Tract Infections in Women: A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial. ( Bonten, MJM; Branger, J; Geerlings, SE; Hassing, RJ; Hoepelman, AIM; Ketels, T; Koldewijn, EL; Koster, A; Kuiper, S; Ten Doesschate, T; van den Bijllaardt, W; van der Bij, AK; van Mens, SP; van Nieuwkoop, C; van Werkhoven, CH, 2022) |
| "Ciprofloxacin was administered intravenously @5 mg/kg body weight to six healthy dogs." | 5.35 | Effect of induced pyrexia on the disposition kinetics of ciprofloxacin in dogs. ( Akhtar, M; Anwar, MI; Arshed, MJ; Muhammad, F, 2009) |
| "Unfortunately, neutropenia is common." | 5.31 | The efficacy of prophylactic outpatient antibiotics for the prevention of neutropenic fever associated with high-dose etoposide (VP-16) for stem cell mobilization. ( Andresen, SW; Avery, RK; Bernhard, L; Bolwell, BJ; Goormastic, M; Kalaycio, ME; Kuczkowski, E; Longworth, DL; Mossad, SB; Ostendorf, H; Pohlman, BL; Sobecks, RM; Wise, K, 2002) |
| "coli urinary tract infections as Alternative Stepdown Treatment) is a randomized, double-blind, double-dummy, non-inferiority trial in which 240 patients will be randomly allocated to a stepdown treatment with FT or ciprofloxacin (standard of care) for FUTI, caused by Escherichia coli with in vitro susceptibility to both antibiotics." | 5.27 | Oral fosfomycin versus ciprofloxacin in women with E.coli febrile urinary tract infection, a double-blind placebo-controlled randomized controlled non-inferiority trial (FORECAST). ( Bonten, MJM; Geerlings, SE; Hoepelman, AIM; Ten Doesschate, T; van Mens, SP; van Nieuwkoop, C, 2018) |
| "Fluoroquinolones reduce occurrence of fever in adult cancer patients who develop neutropenia, but there has been no randomized controlled trial in children, and there are only a few studies considering resistance in intestinal floral after ciprofloxacin has been used." | 5.17 | Ciprofloxacin reduces occurrence of fever in children with acute leukemia who develop neutropenia during chemotherapy. ( Chelae, S; Khwanna, T; Laoprasopwattana, K; Sujjanunt, T; Suwankeeree, P; Tunyapanit, W, 2013) |
| "Ciprofloxacin (CPFX) is a potential alternative in patients with febrile neutropenia (FN) because of its activity against Gram-negative organisms." | 5.17 | Randomized controlled trial comparing ciprofloxacin and cefepime in febrile neutropenic patients with hematological malignancies. ( Atsuta, Y; Emi, N; Inamoto, Y; Ishikawa, Y; Nagai, H; Naoe, T; Ozawa, Y; Ozeki, K; Suzuki, R; Terakura, S; Yanada, M; Yasuda, T, 2013) |
| " After a pre-intervention period, in which cefepime was used as the initial agent for febrile neutropenia, 4 primary antibiotics, namely, piperacillin-tazobactam, ciprofloxacin, meropenem, and cefepime, were rotated at 1-month intervals over 20 months." | 5.17 | Antibiotic rotation for febrile neutropenic patients with hematological malignancies: clinical significance of antibiotic heterogeneity. ( Akashi, K; Chong, Y; Ito, Y; Kamimura, T; Miyamoto, T; Shimoda, S; Shimono, N; Yakushiji, H, 2013) |
| " The present study was designed to evaluate the benefit of intravenous ciprofloxacin for neutropenic patients with fever who were refractory to initial therapy given for the first 3 days." | 5.12 | Efficacy of intravenous ciprofloxacin in patients with febrile neutropenia refractory to initial therapy. ( Kawano, F; Koga, S; Matsuoka, H; Okamura, S; Shibata, K; Shirahashi, A; Suzushima, H; Tamura, K; Tsukamoto, A; Uozumi, K; Yamashita, K, 2006) |
| "An open-label randomised clinical trial was designed to compare the efficacy and tolerance of levofloxacin and ciprofloxacin plus phenethicillin for the prevention of bacterial infections in patients with high-risk neutropenia, and to monitor the emergence of antimicrobial resistance." | 5.12 | Levofloxacin vs. ciprofloxacin plus phenethicillin for the prevention of bacterial infections in patients with haematological malignancies. ( Huijgens, PC; Janssen, JJ; Leidekker, ME; Simoons-Smit, AM; Timmers, GJ; Vandenbroucke-Grauls, CM, 2007) |
| "To determine whether ciprofloxacin-piperacillin is equivalent to tobramycin-piperacillin as empirical therapy for neutropenic fever." | 5.10 | Ciprofloxacin plus piperacillin compared with tobramycin plus piperacillin as empirical therapy in febrile neutropenic patients. A randomized, double-blind trial. ( Cushing, DA; Donowitz, GR; Harman, CP; Haverstock, DC; Herrington, DA; Hurd, DD; Kowalsky, SF; Lazarus, HM; Peacock, JE; Reed, MD; Sinclair, JW; Wade, JC, 2002) |
| "In low-risk patients with cancer who have fever and granulocytopenia, oral therapy with ciprofloxacin plus amoxicillin-clavulanate is as effective as intravenous therapy." | 5.09 | Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy. International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Can ( Cometta, A; De Bock, R; Gaya, H; Kern, WV; Langenaeken, J; Paesmans, M, 1999) |
| "To determine whether the addition of rifampin to a quinolone-based antibacterial prophylactic regimen in patients undergoing high-dose chemotherapy (HDC) with peripheral-blood stem-cell transplantation (PBSCT) decreases the incidence of neutropenia and fever, Gram-positive bacteremia, and infection-related morbidity." | 5.09 | Rifampin does not improve the efficacy of quinolone antibacterial prophylaxis in neutropenic cancer patients: results of a randomized clinical trial. ( Arcediano, A; Cortés-Funes, H; Gomez-Martin, C; Hidalgo, M; Hornedo, J; Lumbreras, C; Perea, S; Rodriguez, M; Salazar, R; Solá, C; Valentí, V, 2000) |
| "This intervention influenced administration of ciprofloxacin without apparent compromise of patient outcomes and resulted in a reduction in total costs of treating febrile neutropenia." | 5.09 | A new ciprofloxacin stepdown program in the treatment of high-risk febrile neutropenia: a clinical and economic analysis. ( de Lemos, ML; Frighetto, L; Jewesson, PJ; Marra, CA; Marra, F; Quaia, CB; Warkentin, DI, 2000) |
| "Low-risk patients (N = 70) with episodes of fever and neutropenia (N = 116) were randomized to receive either oral ciprofloxacin or intravenous ceftriaxone as outpatients." | 5.09 | Oral ciprofloxacin vs. intravenous ceftriaxone administered in an outpatient setting for fever and neutropenia in low-risk pediatric oncology patients: randomized prospective trial. ( Campos, MC; Dantas, LS; Ginani, VC; Petrilli, AS; Seber, A; Tanaka, C, 2000) |
| "The objective of this study was to test the efficacy of oral ciprofloxacin in the treatment of lower risk febrile neutropenia (LRFN) in children treated for malignant diseases." | 5.09 | Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia. ( Armada, A; Cáceres, E; Casimir, L; Debbag, R; Fernández, C; Firpo, V; Latella, A; Paganini, H; Rodriguez-Brieshcke, T; Zubizarreta, P, 2001) |
| "In hospitalized low-risk patients who have fever and neutropenia during cancer chemotherapy, empirical therapy with oral ciprofloxacin and amoxicillin-clavulanate is safe and effective." | 5.09 | A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy. ( Chanock, S; Freifeld, A; Gill, V; Hicks, JE; Hiemenz, J; Hiemenz, S; Lewis, L; Marchigiani, D; Pizzo, PA; Steinberg, SM; Walsh, T, 1999) |
| "In a prospective randomized trial, 40 stage IV breast cancer patients undergoing intermediate high-dose chemotherapy (cyclophosphamide, 5-fluorouracil plus epirubicin or methotrexate), received either recombinant human G-CSF (rhG-CSF, group I) or ciprofloxacin and amphotericin B (CAB, group II) for prevention of febrile leucopenia (FL)." | 5.09 | Prevention of febrile leucopenia after chemotherapy in high-risk breast cancer patients: no significant difference between granulocyte-colony stimulating growth factor or ciprofloxacin plus amphotericin B. ( de Vries, EG; Hospers, GA; Mulder, NH; Schröder, CP; Sleijfer, DT; van der Graaf, WT; Willemse, PH, 1999) |
| "The purpose of this study was to test the comparative efficacy and toxicity of empiric gentamicin and ciprofloxacin, in combination with piperacillin, in febrile patients with treatment-induced neutropenia." | 5.08 | Ciprofloxacin plus piperacillin is an equally effective regimen for empiric therapy in febrile neutropenic patients compared with standard therapy. ( Betts, RF; Blair, EA; Flesher, WR; Griggs, JJ; Norton, JR; Rowe, JM, 1998) |
| "Teicoplanin plus ciprofloxacin was compared with gentamicin plus piperacillin for the empirical treatment of fever in 80 neutropenic patients." | 5.07 | Teicoplanin plus ciprofloxacin versus gentamicin plus piperacillin in the treatment of febrile neutropenic patients. ( Collins, PW; Kelsey, SM; Newland, AC; Weinhardt, B, 1992) |
| " The use of monotherapy with intravenous ciprofloxacin (200 to 300 mg every 12 h) was evaluated against combined therapy with piperacillin plus amikacin in febrile granulocytopenic patients with solid tumor or lymphoma." | 5.07 | Prospective randomized evaluation of ciprofloxacin versus piperacillin plus amikacin for empiric antibiotic therapy of febrile granulocytopenic cancer patients with lymphomas and solid tumors. The European Organization for Research on Treatment of Cancer ( Calandra, T; Gaya, H; Glauser, M; Klastersky, J; Meunier, F; Viscoli, C; Zinner, SH, 1991) |
| "More patients receiving ciprofloxacin did not develop fever during neutropenia and did not receive antibiotics (34%) compared with those receiving norfloxacin (25%) (P = 0." | 5.07 | Prevention of bacterial infection in neutropenic patients with hematologic malignancies. A randomized, multicenter trial comparing norfloxacin with ciprofloxacin. The GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. ( , 1991) |
| "We studied the effectiveness of prophylactic oral ciprofloxacin and rifampin on fever prevention in patients undergoing autologous bone marrow transplantation (ABMT) for breast cancer." | 5.07 | Sequential prophylactic oral and empiric once-daily parenteral antibiotics for neutropenia and fever after high-dose chemotherapy and autologous bone marrow support. ( Gilbert, C; Hussein, A; Meisenberg, B; Perfect, J; Peters, WP; Ross, M; Vredenburgh, J, 1994) |
| "We compared the combination of teicoplanin plus ciprofloxacin with gentamicin plus piperacillin for the empirical treatment of fever in 80 neutropenic patients." | 5.06 | A randomized study of teicoplanin plus ciprofloxacin versus gentamicin plus piperacillin for the empirical treatment of fever in neutropenic patients. ( Collins, PW; Delord, C; Kelsey, SM; Newland, AC; Weinhard, B, 1990) |
| "We examined the efficacy of ciprofloxacin as an empirical treatment for fever in 97 neutropenic patients in a randomized study of ciprofloxacin and benzylpenicillin versus netilmicin and piperacillin." | 5.06 | A comparative study of intravenous ciprofloxacin and benzylpenicillin versus netilmicin and piperacillin for the empirical treatment of fever in neutropenic patients. ( Jenkins, GC; Kelsey, SM; Newland, AC; Shaw, E; Wood, ME, 1990) |
| "This study developed further clinical experience in using a single agent ("monotherapy") as empirical treatment for neutropenic patients with fever, and compared the safety and toxicity of two candidate agents, ceftazidime and ciprofloxacin." | 5.06 | A prospective, randomized comparison of ceftazidime and ciprofloxacin as initial empiric therapy in neutropenic patients with fever. ( Bayston, KF; Cohen, J; Want, S, 1989) |
| "In a multicenter, randomized clinical trial, the efficacy of ciprofloxacin plus azlocillin was compared with that of a standard regimen of ceftazidime plus amikacin for the initial empiric treatment of fever in neutropenic cancer patients." | 5.06 | Multicenter, randomized trial of ciprofloxacin plus azlocillin versus ceftazidime plus amikacin for empiric treatment of febrile neutropenic patients. ( Arnow, P; Edlin, B; Flaherty, JP; George, D; O'Keefe, P; Waitley, D; Weinstein, RA, 1989) |
| "In a double-blind, randomized, placebo-controlled trial 50 adult patients with acute diarrhea received either 500 mg ciprofloxacin b." | 5.06 | Ciprofloxacin in the treatment of acute bacterial diarrhea: a double blind study. ( Diridl, G; Pichler, H; Wolf, D, 1986) |
| "To assess the efficacy of ciprofloxacin in neutropenic patients, we conducted a randomized prospective trial comparing the combination of ciprofloxacin and netilmicin against piperacillin plus netilmicin as an empiric treatment of fever in cancer patients with neutropenia." | 5.06 | Randomized trial comparing ciprofloxacin plus netilmicin versus piperacillin plus netilmicin for empiric treatment of fever in neutropenic patients. ( Anderson, H; Chan, CC; Oppenheim, BA; Scarffe, JH; Swindell, R, 1989) |
| "To compare the effectiveness and toxicity of ciprofloxacin vs an aminoglycoside, both in combination with a beta-lactam, for the treatment of febrile neutropenia in the inpatient setting." | 4.82 | Ciprofloxacin vs an aminoglycoside in combination with a beta-lactam for the treatment of febrile neutropenia: a meta-analysis of randomized controlled trials. ( Bliziotis, IA; Christodoulou, C; Chrysanthopoulou, S; Falagas, ME; Kasiakou, SK; Michalopoulos, A; Samonis, G, 2005) |
| "In this retrospective study, we analyzed the clinical data and outcome of patients with AML who did or did not receive prophylactic ciprofloxacin 500 mg BD for neutropenic fever." | 3.83 | Prophylaxis of neutropenic fever with ciprofloxacin in patients with acute myeloid leukemia treated with intensive chemotherapy. ( Foratyazdi, M; Ghadiany, M; Mehdizadeh, M; Mohammad Alizadeh, A; Rahimi, H; Rezvani, H; Zamani, N, 2016) |
| "This study seeks to determine the incidence of vancomycin-resistant enterococci (VRE) infection in high-risk neutropenic fever patients colonized with VRE and to determine patient characteristics associated with VRE infection." | 3.76 | Incidence of vancomycin-resistant enterococci (VRE) infection in high-risk febrile neutropenic patients colonized with VRE. ( Bossaer, JB; Garrett-Mayer, E; Hall, PD, 2010) |
| "The objective of this investigation was to assess retrospectively the safety and the efficacy of oral ciprofloxacin plus cefuroxime axetil compared to the combination of oral ciprofloxacin plus amoxicillin/clavulanate, as initial outpatient treatment, in low-risk cancer patients with fever and neutropenia." | 3.74 | Comparison of two oral regimens for the outpatient treatment of low-risk cancer patients with chemotherapy-induced neutropenia and fever: ciprofloxacin plus cefuroxime axetil versus ciprofloxacin plus amoxicillin/clavulanate. ( Karabelis, A; Kordossis, T; Kosmas, C; Sipsas, NV; Skopelitis, E; Tsavaris, N; Vadiaka, M; Ziakas, PD, 2007) |
| "Of the 60 consecutive patients who received neoadjuvant chemotherapy as a phase II trial of docetaxel (60 mg/m(2)) and doxorubicin (50 mg/m(2)) for primary breast cancer, 30 low-risk febrile patients received oral ciprofloxacin." | 3.74 | The outpatient management of low-risk febrile patients with neutropenia: risk assessment over the telephone. ( Ando, M; Katsumata, N; Mizuno, T; Mukai, H; Shimizu, C; Watanabe, T, 2007) |
| "Suspecting typhoid fever with ciprofloxacin was started." | 3.71 | [Fever and calf tenderness after travel in Thailand: murine typhus and deep vein thrombosis]. ( Döller, PC; Slesak, G, 2001) |
| "The influence of fever on the pharmacokinetics of ciprofloxacin was investigated in seven patients with acute febrile diseases." | 3.70 | Influence of fever on the pharmacokinetics of ciprofloxacin. ( Belic, A; Beovic, B; Grabnar, I; Karba, R; Marolt-Gomiscek, M; Mrhar, A; Zupancic, T, 1999) |
| " As the mild signs of interstitial pneumonia progressed, clarithromycin (500 mg twice daily orally) was substituted with rapid fall in fever and gradual improvement." | 3.70 | [Tsutsugamushi fever. Rare rickettsiosis after a stay in the Philippines]. ( Fischer, BP; Hahn, EG; Müller, A; Schneider, HT; Strauss, R, 1998) |
| " We evaluated retrospectively the effect of antibiotic prophylaxis with ciprofloxacin and penicillin on the prevention of bacterial infections in 112 cases of prolonged neutropenia in adult patients treated for haematological malignancies." | 3.70 | [Evaluation of antibiotic prophylaxis in neutropenic patients with hematologic malignancies]. ( Baumgartner, JD; Cometta, A; Delarive, P; Glauser, MP, 2000) |
| "To assess the value of prophylactic ciprofloxacin in reducing the incidence of neutropenic fever in men receiving intensive chemotherapy for germ cell tumours, we reviewed the case notes of 88 consecutive patients treated between January 1986 and December 1992." | 3.69 | Chemotherapy for germ cell tumours: prophylactic ciprofloxacin reduces the incidence of neutropenic fever. ( Counsell, R; Pratt, J; Williams, MV, 1994) |
| "We studied the efficacy of piperacillin and ciprofloxacin as initial parenteral therapy in 41 adult patients with leukemia who developed 47 febrile episodes during severe neutropenia following chemotherapy." | 3.68 | A pilot study of piperacillin and ciprofloxacin as initial therapy for fever in severely neutropenic leukemia patients. ( Lerner, R; Nilsson, PG; Palmblad, J; Samuelsson, J; Wahlin, A; Winqvist, I, 1992) |
| "Twenty-four episodes of fever in neutropenic patients with haematological malignancy were treated with ciprofloxacin." | 3.67 | Preliminary evaluation of ciprofloxacin, a new 4-quinolone antibiotic, in the treatment of febrile neutropenic patients. ( Farrell, ID; Geddes, AM; Leyland, MJ; Smith, GM, 1986) |
| "Forty-six episodes of fever in 34 patients with neutropenia and haematological malignancy were treated empirically with a combination of ciprofloxacin and vancomycin." | 3.67 | A clinical, microbiological and pharmacokinetic study of ciprofloxacin plus vancomycin as initial therapy of febrile episodes in neutropenic patients. ( Farrell, ID; Geddes, AM; Leyland, MJ; Smith, GM, 1988) |
| "Inclusion criteria were cancer, febrile neutropenia, low risk of complications as predicted by a Multinational Association for Supportive Care in Cancer (MASCC) score > 20, ability to swallow, and ≤ one single intravenous dose of empiric antibiotic therapy before study drug treatment initiation." | 2.78 | Oral antibiotics for fever in low-risk neutropenic patients with cancer: a double-blind, randomized, multicenter trial comparing single daily moxifloxacin with twice daily ciprofloxacin plus amoxicillin/clavulanic acid combination therapy--EORTC infectiou ( Akan, H; Akova, M; Aoun, M; Calandra, T; de Bock, R; Drgona, L; Kern, WV; Marchetti, O; Paesmans, M; Viscoli, C, 2013) |
| "The standard treatment of fever in chemotherapy-induced neutropenia (FN) includes emergency hospitalization and empirical intravenous antimicrobial therapy." | 2.77 | First-day step-down to oral outpatient treatment versus continued standard treatment in children with cancer and low-risk fever in neutropenia. A randomized controlled trial within the multicenter SPOG 2003 FN study. ( Ammann, RA; Bodmer, N; Brack, E; Kühne, T; Leibundgut, K; Niggli, FK; Simon, A, 2012) |
| " Daily assessments were made of all patients and all adverse events were recorded." | 2.73 | A prospective, controlled, randomized, non-blind, comparative study of the efficacy and safety of a once daily high dose of ceftriaxone plus ciprofloxacin versus thrice daily ceftazidime plus amikacin in empirical therapy for febrile neutropenic patients. ( Giannakakis, T; Hatzitolios, A; Kollaras, P; Kordosis, T; Metallidis, S; Nikolaidis, J; Nikolaidis, P; Seitanidis, B, 2008) |
| "Ciprofloxacin was the most frequently studied drug." | 2.72 | Systematic review: the bioavailability of orally administered antibiotics during the initial phase of a systemic infection in non-ICU patients. ( Prins, JM; van den Broek, AK; van Hest, RM; Visser, CE, 2021) |
| "Metronidazole was added to the ciprofloxacin-amoxicillin regimen where anaerobic infection was suspected." | 2.71 | Piperacillin-tazobactam versus ciprofloxacin plus amoxicillin in the treatment of infective episodes after liver transplantation. ( Burroughs, A; Fisher, N; Hastings, M; Kibbler, C; Mutimer, D; O'Grady, J; Patch, D; Philpott-Howard, J; Rolando, N; Wade, J; Wendon, J, 2003) |
| "Pediatric cancer patients presenting with febrile neutropenia after non-myeloablative chemotherapy and who met institutional criteria for early hospital discharge following a minimum of 48-hr inpatient empiric intravenous ceftazidime were eligible for the study." | 2.71 | Ciprofloxacin and amoxicillin as continuation treatment of febrile neutropenia in pediatric cancer patients. ( Burns, JL; Coughlin, J; Friedman, DL; Hawkins, D; Park, JR; Pendergrass, T, 2003) |
| "We treated low-risk febrile neutropenic cancer patients utilizing two standard outpatient antibiotic pathways: oral ampicillin/clavulanate (500 mg) and ciprofloxacin (500 mg) or intravenous ceftazidime (2 g) and clindamycin (600 mg) every 8 h." | 2.71 | Outcomes of treatment pathways in outpatient treatment of low risk febrile neutropenic cancer patients. ( Badrina, N; Benjamin, R; DeJesus, Y; Escalante, CP; Fernandez, S; Ho, V; Lam, T; Lee, EL; Manzullo, E; Rivera, E; Rolston, K; Valdres, R; Weiser, MA, 2004) |
| "Neutropenic fever is one of the most serious adverse effects of cancer chemotherapy." | 2.71 | Randomized trial of oral versus intravenous antibiotics in low-risk febrile neutropenic patients with lung cancer. ( Goto, K; Kakinuma, R; Kubota, K; Matsumoto, T; Niho, S; Nishiwaki, Y; Ohe, Y; Ohmatsu, H, 2004) |
| "Ciprofloxacin was associated with a low incidence of adverse events with skin rash (five cases) and nausea (one case) being reported as possibly or probably related to ciprofloxacin." | 2.67 | High dose intravenous ciprofloxacin in febrile neutropenic patients. ( Johnson, PR; Tooth, JA; Yin, JA, 1990) |
| "There were five superinfections, all in the gentamicin/azlocillin group." | 2.67 | Randomized multicentre study of ciprofloxacin and azlocillin versus gentamicin and azlocillin in the treatment of febrile neutropenic patients. ( Barker, KF; Kaczmarski, RS; Mufti, GJ; Philpott-Howard, JN; Smedley, JC; Wade, JJ, 1990) |
| "Ciprofloxacin was therefore superior to the other two fluoroquinolones in preventing infections due to Gram-negative bacteria in this population of neutropenic patients." | 2.67 | Comparison of ciprofloxacin, ofloxacin and pefloxacin for the prevention of the bacterial infection in neutropenic patients with haematological malignancies. ( Accorsi, P; Betti, S; D'Antonio, D; Dell'Isola, M; Favalli, C; Fioritoni, G; Iacone, A; Parruti, G; Piccolomini, R; Quaglietta, AM, 1994) |
| "Thus, up to date management of cancer patients, in addition to other supportive care modalities, should also incorporate diagnostic methods and therapy of infections." | 2.47 | [Treatment and prevention of infections in cancer patients with neutropenia]. ( Sinkó, J, 2011) |
| "Allergic interstitial nephritis is believed to be the underlying pathological-process." | 2.38 | Ciprofloxacin-induced nephrotoxicity in patients with cancer. ( Bodey, GP; Lo, WK; Rolston, KV; Rubenstein, EB, 1993) |
| "We sought to describe the risk of recurrence at 1 month after the end of treatment for FUTI due to ESBL-E according to the oral relay therapy used." | 1.62 | Relay oral therapy in febrile urinary tract infections caused by extended spectrum beta-lactamase-producing Enterobacteriaceae in children: A French multicenter study. ( Andriantahina, I; Angoulvant, F; Birgy, A; Bonacorsi, S; Cixous, E; Cohen, R; Craiu, I; De Pontual, L; Dommergues, MA; Dubos, F; Gajdos, V; Georget, E; Gillet, Y; Grimprel, E; Jung, C; Launay, E; Levy, C; Lignieres, G; Madhi, F; Pinquier, D; Rybak, A; Soussan-Banini, V; Vignaud, O, 2021) |
| "Typhoid fever is a vaccine-preventable bacterial disease that causes significant morbidity and mortality throughout Africa." | 1.48 | Investigation of a typhoid fever epidemic in Moyale Sub-County, Kenya, 2014-2015. ( Abill, K; Boru, WG; Galgallo, DA; Ransom, J; Roka, ZG, 2018) |
| "Around 2090 confirmed cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) from 27 countries have been reported to the World Health Organization (WHO) between September 2012 and October 2017, the majority of whom occurring in countries in the Arabian Peninsula, mainly in Saudi Arabia." | 1.48 | Atypical presentation of Middle East respiratory syndrome coronavirus in a Lebanese patient returning from Saudi Arabia. ( El Zein, S; Ghosn, N; Kanj, SS; Khraibani, J; Mahfouz, R; Zahreddine, N, 2018) |
| "Transient fever is commonly reported as a side effect." | 1.40 | Hepatic cyst infection following aspiration sclerotherapy: a case series. ( Drenth, JP; Lantinga, MA; Wijnands, TF, 2014) |
| "The period of S." | 1.37 | Effect of biofilm formation on the excretion of Salmonella enterica serovar Typhi in feces. ( Ali, A; Haque, A; Jamil, A; Raza, A; Sarwar, Y, 2011) |
| "Ciprofloxacin was administered intravenously @5 mg/kg body weight to six healthy dogs." | 1.35 | Effect of induced pyrexia on the disposition kinetics of ciprofloxacin in dogs. ( Akhtar, M; Anwar, MI; Arshed, MJ; Muhammad, F, 2009) |
| "Unfortunately, neutropenia is common." | 1.31 | The efficacy of prophylactic outpatient antibiotics for the prevention of neutropenic fever associated with high-dose etoposide (VP-16) for stem cell mobilization. ( Andresen, SW; Avery, RK; Bernhard, L; Bolwell, BJ; Goormastic, M; Kalaycio, ME; Kuczkowski, E; Longworth, DL; Mossad, SB; Ostendorf, H; Pohlman, BL; Sobecks, RM; Wise, K, 2002) |
| "Ehrlichiosis is an emerging zoonotic disease transmitted to man by ticks." | 1.30 | [Monocytic ehrlichiosis--an emerging zoonotic disease in Israel]. ( Potasman, I; Zikonov, I, 1999) |
| "Ciprofloxacin was therefore incorporated into the prophylactic antibiotic regimen during allogeneic bone marrow or peripheral blood stem cell transplantation at Veterans General Hospital, Kaohsiung from February 1997." | 1.30 | Oral ciprofloxacin as antibacterial prophylaxis after allogeneic bone marrow transplantation: a reappraisal. ( Hsueh, EJ; Wang, YC; Wu, H; Yeh, SP; Yu, MS, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (5.38) | 18.7374 |
| 1990's | 36 (27.69) | 18.2507 |
| 2000's | 46 (35.38) | 29.6817 |
| 2010's | 35 (26.92) | 24.3611 |
| 2020's | 6 (4.62) | 2.80 |
| Authors | Studies |
|---|---|
| Lignieres, G | 1 |
| Birgy, A | 1 |
| Jung, C | 1 |
| Bonacorsi, S | 1 |
| Levy, C | 1 |
| Angoulvant, F | 1 |
| Grimprel, E | 1 |
| Dommergues, MA | 1 |
| Gillet, Y | 1 |
| Craiu, I | 1 |
| Rybak, A | 1 |
| De Pontual, L | 1 |
| Dubos, F | 1 |
| Cixous, E | 1 |
| Gajdos, V | 1 |
| Pinquier, D | 1 |
| Andriantahina, I | 1 |
| Soussan-Banini, V | 1 |
| Georget, E | 1 |
| Launay, E | 1 |
| Vignaud, O | 1 |
| Cohen, R | 1 |
| Madhi, F | 1 |
| Ten Doesschate, T | 2 |
| Kuiper, S | 1 |
| van Nieuwkoop, C | 4 |
| Hassing, RJ | 1 |
| Ketels, T | 1 |
| van Mens, SP | 2 |
| van den Bijllaardt, W | 1 |
| van der Bij, AK | 1 |
| Geerlings, SE | 2 |
| Koster, A | 1 |
| Koldewijn, EL | 1 |
| Branger, J | 1 |
| Hoepelman, AIM | 2 |
| van Werkhoven, CH | 1 |
| Bonten, MJM | 2 |
| Van Den Broek, AK | 4 |
| Visser, CE | 4 |
| Veenstra, J | 3 |
| Van Den Berg, BTJ | 3 |
| Prins, JM | 4 |
| Van Hest, RM | 4 |
| Le Dault, E | 1 |
| Sicard, S | 1 |
| Desplans, J | 1 |
| Mayet, A | 1 |
| Simon, F | 1 |
| Aigle, L | 1 |
| Savini, H | 1 |
| Coton, T | 1 |
| Marimoutou, C | 1 |
| Çağatay, AA | 1 |
| Deniz, R | 1 |
| Gözüküçük, R | 1 |
| Özbek, E | 1 |
| Başaran, S | 1 |
| El Zein, S | 1 |
| Khraibani, J | 1 |
| Zahreddine, N | 1 |
| Mahfouz, R | 1 |
| Ghosn, N | 1 |
| Kanj, SS | 1 |
| Antonitsch, L | 1 |
| Weidinger, G | 1 |
| Stanek, G | 1 |
| Markowicz, M | 1 |
| van der Starre, WE | 1 |
| Stalenhoef, JE | 1 |
| van Aartrijk, AM | 1 |
| van der Reijden, TJ | 1 |
| Vollaard, AM | 1 |
| Delfos, NM | 2 |
| van 't Wout, JW | 1 |
| Blom, JW | 2 |
| Spelt, IC | 2 |
| Leyten, EM | 2 |
| Koster, T | 2 |
| Ablij, HC | 2 |
| van der Beek, MT | 1 |
| Knol, MJ | 1 |
| van Dissel, JT | 2 |
| Ferstl, PG | 1 |
| Reinheimer, C | 1 |
| Jozsa, K | 1 |
| Zeuzem, S | 1 |
| Kempf, VA | 1 |
| Waidmann, O | 1 |
| Grammatikos, G | 1 |
| Kawasaki, Y | 1 |
| Matsubara, K | 1 |
| Takahashi, H | 1 |
| Morita, M | 1 |
| Ohnishi, M | 1 |
| Hori, M | 1 |
| Isome, K | 1 |
| Iwata, A | 1 |
| Nigami, H | 1 |
| Ikemachi, M | 1 |
| Yamamoto, G | 1 |
| Ohkusu, K | 1 |
| Elshal, AM | 1 |
| Atwa, AM | 1 |
| El-Nahas, AR | 1 |
| El-Ghar, MA | 1 |
| Gaber, A | 1 |
| Elsawy, E | 1 |
| Hashem, A | 1 |
| Farag, Y | 1 |
| Farg, H | 1 |
| Elsorougy, A | 1 |
| Fouda, M | 1 |
| Nabeeh, H | 1 |
| Mosbah, A | 1 |
| Galgallo, DA | 1 |
| Roka, ZG | 1 |
| Boru, WG | 1 |
| Abill, K | 1 |
| Ransom, J | 1 |
| Bloch, C | 1 |
| Friedl, A | 1 |
| Zucol, F | 1 |
| Widmer, A | 1 |
| Khanna, N | 1 |
| Castagnola, E | 1 |
| Moroni, C | 1 |
| Bandettini, R | 1 |
| Caprino, D | 1 |
| Haupt, R | 1 |
| Fatima, A | 1 |
| Afridi, FI | 1 |
| Qureshi, A | 1 |
| Farooqi, BJ | 1 |
| Hussain, A | 1 |
| Ghadiany, M | 1 |
| Rahimi, H | 1 |
| Rezvani, H | 1 |
| Mohammad Alizadeh, A | 1 |
| Zamani, N | 1 |
| Mehdizadeh, M | 1 |
| Foratyazdi, M | 1 |
| Heidari Bateni, Z | 1 |
| Shahrokh, H | 1 |
| Salimi, H | 1 |
| Safari, H | 1 |
| Tabatabai, M | 1 |
| Saedi, D | 1 |
| Wijnands, TF | 1 |
| Lantinga, MA | 1 |
| Drenth, JP | 1 |
| Mayer, K | 1 |
| Hahn-Ast, C | 1 |
| Mückter, S | 1 |
| Schmitz, A | 1 |
| Krause, S | 1 |
| Felder, L | 1 |
| Bekeredjian-Ding, I | 1 |
| Molitor, E | 1 |
| Brossart, P | 1 |
| von Lilienfeld-Toal, M | 1 |
| Levine, AC | 1 |
| Shetty, PP | 1 |
| Henwood, PC | 1 |
| Sabeti, P | 1 |
| Katz, JT | 1 |
| Vaidya, A | 1 |
| James, J | 1 |
| Kaul, DR | 1 |
| Goldberger, ZD | 1 |
| Saint, S | 1 |
| Skerrett, SJ | 1 |
| Lee, DS | 1 |
| Choe, HS | 1 |
| Kim, HY | 1 |
| Yoo, JM | 1 |
| Bae, WJ | 1 |
| Cho, YH | 1 |
| Kim, SW | 1 |
| Han, CH | 1 |
| Bae, SR | 1 |
| Jang, H | 1 |
| Park, SB | 1 |
| Yoon, BI | 1 |
| Lee, SJ | 1 |
| Metallidis, S | 1 |
| Kollaras, P | 1 |
| Giannakakis, T | 1 |
| Seitanidis, B | 1 |
| Kordosis, T | 1 |
| Nikolaidis, J | 1 |
| Hatzitolios, A | 1 |
| Nikolaidis, P | 1 |
| van't Wout, JW | 1 |
| Assendelft, WJ | 1 |
| Elzevier, HW | 1 |
| Wattel-Louis, GH | 1 |
| Kuijper, EJ | 1 |
| Pander, J | 1 |
| Muhammad, F | 1 |
| Akhtar, M | 1 |
| Anwar, MI | 1 |
| Arshed, MJ | 1 |
| Bossaer, JB | 1 |
| Hall, PD | 1 |
| Garrett-Mayer, E | 1 |
| Eleutherakis-Papaiakovou, E | 1 |
| Kostis, E | 1 |
| Migkou, M | 1 |
| Christoulas, D | 1 |
| Terpos, E | 1 |
| Gavriatopoulou, M | 1 |
| Roussou, M | 1 |
| Bournakis, E | 1 |
| Kastritis, E | 1 |
| Efstathiou, E | 1 |
| Dimopoulos, MA | 1 |
| Papadimitriou, CA | 1 |
| Edlich, RF | 1 |
| Bhattacharya, SS | 1 |
| Das, U | 1 |
| Choudhury, BK | 1 |
| Raza, A | 1 |
| Sarwar, Y | 1 |
| Ali, A | 1 |
| Jamil, A | 1 |
| Haque, A | 2 |
| Sinkó, J | 1 |
| Loeb, S | 1 |
| van den Heuvel, S | 1 |
| Zhu, X | 1 |
| Bangma, CH | 1 |
| Schröder, FH | 1 |
| Roobol, MJ | 1 |
| Brack, E | 1 |
| Bodmer, N | 1 |
| Simon, A | 1 |
| Leibundgut, K | 1 |
| Kühne, T | 1 |
| Niggli, FK | 1 |
| Ammann, RA | 1 |
| Seas, C | 1 |
| Villaverde, H | 1 |
| Maguiña, C | 1 |
| Mullen, CA | 3 |
| Coutinho, AS | 1 |
| de Morais, OO | 1 |
| Gomes, CM | 1 |
| de Oliveira Carneiro da Motta, J | 1 |
| Laoprasopwattana, K | 1 |
| Khwanna, T | 1 |
| Suwankeeree, P | 1 |
| Sujjanunt, T | 1 |
| Tunyapanit, W | 1 |
| Chelae, S | 1 |
| Rodríguez Collar, TL | 1 |
| Valdés Estévez, B | 1 |
| Nuñez Roca, A | 1 |
| Germán Meliz, JL | 1 |
| Yasuda, T | 1 |
| Suzuki, R | 1 |
| Ishikawa, Y | 1 |
| Terakura, S | 1 |
| Inamoto, Y | 1 |
| Yanada, M | 1 |
| Nagai, H | 1 |
| Ozawa, Y | 1 |
| Ozeki, K | 1 |
| Atsuta, Y | 1 |
| Emi, N | 1 |
| Naoe, T | 1 |
| Slavin, MA | 1 |
| Thursky, KA | 1 |
| Kern, WV | 2 |
| Marchetti, O | 1 |
| Drgona, L | 1 |
| Akan, H | 1 |
| Aoun, M | 1 |
| Akova, M | 1 |
| de Bock, R | 2 |
| Paesmans, M | 2 |
| Viscoli, C | 2 |
| Calandra, T | 2 |
| Chong, Y | 1 |
| Shimoda, S | 1 |
| Yakushiji, H | 1 |
| Ito, Y | 1 |
| Miyamoto, T | 1 |
| Kamimura, T | 1 |
| Shimono, N | 1 |
| Akashi, K | 1 |
| Peacock, JE | 1 |
| Herrington, DA | 1 |
| Wade, JC | 1 |
| Lazarus, HM | 1 |
| Reed, MD | 1 |
| Sinclair, JW | 1 |
| Haverstock, DC | 1 |
| Kowalsky, SF | 1 |
| Hurd, DD | 1 |
| Cushing, DA | 1 |
| Harman, CP | 1 |
| Donowitz, GR | 1 |
| Avery, RK | 1 |
| Pohlman, BL | 1 |
| Mossad, SB | 1 |
| Goormastic, M | 1 |
| Longworth, DL | 1 |
| Kalaycio, ME | 1 |
| Sobecks, RM | 1 |
| Andresen, SW | 1 |
| Kuczkowski, E | 1 |
| Bernhard, L | 1 |
| Ostendorf, H | 1 |
| Wise, K | 1 |
| Bolwell, BJ | 1 |
| Park, JR | 1 |
| Coughlin, J | 1 |
| Hawkins, D | 1 |
| Friedman, DL | 1 |
| Burns, JL | 1 |
| Pendergrass, T | 1 |
| Veliev, EI | 1 |
| Bodey, GP | 2 |
| Rolston, KV | 3 |
| Raad, II | 1 |
| Linkin, DR | 1 |
| Fishman, N | 1 |
| Smolyakov, R | 1 |
| Talalay, B | 1 |
| Yanai-Inbar, I | 1 |
| Pak, I | 1 |
| Alkan, M | 1 |
| Paganini, H | 3 |
| Gómez, S | 1 |
| Ruvinsky, S | 1 |
| Zubizarreta, P | 3 |
| Latella, A | 2 |
| Fraquelli, L | 1 |
| Iturres, AS | 1 |
| Casimir, L | 2 |
| Debbag, R | 2 |
| Ulleryd, P | 1 |
| Sandberg, T | 1 |
| Philpott-Howard, J | 1 |
| Burroughs, A | 1 |
| Fisher, N | 1 |
| Hastings, M | 1 |
| Kibbler, C | 1 |
| Mutimer, D | 1 |
| Patch, D | 1 |
| Rolando, N | 1 |
| Wade, J | 1 |
| Wendon, J | 1 |
| O'Grady, J | 1 |
| Cometta, A | 3 |
| Kern, W | 1 |
| Niho, S | 1 |
| Ohe, Y | 1 |
| Goto, K | 1 |
| Ohmatsu, H | 1 |
| Matsumoto, T | 1 |
| Kubota, K | 1 |
| Kakinuma, R | 1 |
| Nishiwaki, Y | 1 |
| Escalante, CP | 1 |
| Weiser, MA | 1 |
| Manzullo, E | 2 |
| Benjamin, R | 1 |
| Rivera, E | 1 |
| Lam, T | 1 |
| Ho, V | 1 |
| Valdres, R | 1 |
| Lee, EL | 1 |
| Badrina, N | 1 |
| Fernandez, S | 1 |
| DeJesus, Y | 1 |
| Rolston, K | 2 |
| Honnef, D | 1 |
| Truong, HT | 1 |
| Mühlenbruch, G | 1 |
| Rókusz, L | 1 |
| László, L | 1 |
| Paul, M | 1 |
| Leibovici, L | 1 |
| Bliziotis, IA | 1 |
| Michalopoulos, A | 1 |
| Kasiakou, SK | 1 |
| Samonis, G | 1 |
| Christodoulou, C | 1 |
| Chrysanthopoulou, S | 1 |
| Falagas, ME | 2 |
| Timmer-Bonte, JN | 1 |
| de Boo, TM | 1 |
| Smit, HJ | 1 |
| Biesma, B | 1 |
| Wilschut, FA | 1 |
| Cheragwandi, SA | 1 |
| Termeer, A | 1 |
| Hensing, CA | 1 |
| Akkermans, J | 1 |
| Adang, EM | 1 |
| Bootsma, GP | 1 |
| Tjan-Heijnen, VC | 2 |
| Morris, P | 1 |
| O'Sullivan, E | 1 |
| Choo, M | 1 |
| Barry, C | 1 |
| Thompson, CJ | 1 |
| Mizuno, T | 1 |
| Katsumata, N | 1 |
| Mukai, H | 1 |
| Shimizu, C | 1 |
| Ando, M | 1 |
| Watanabe, T | 1 |
| Matsuoka, H | 1 |
| Tsukamoto, A | 1 |
| Shirahashi, A | 1 |
| Koga, S | 1 |
| Suzushima, H | 1 |
| Shibata, K | 1 |
| Uozumi, K | 1 |
| Yamashita, K | 1 |
| Okamura, S | 1 |
| Kawano, F | 1 |
| Tamura, K | 1 |
| Moraitou, E | 1 |
| Karydis, I | 1 |
| Nikita, D | 1 |
| Timmers, GJ | 1 |
| Simoons-Smit, AM | 1 |
| Leidekker, ME | 1 |
| Janssen, JJ | 1 |
| Vandenbroucke-Grauls, CM | 1 |
| Huijgens, PC | 1 |
| Bindu, M | 1 |
| Vengamma, B | 1 |
| Kumar, G | 1 |
| Sipsas, NV | 1 |
| Kosmas, C | 1 |
| Ziakas, PD | 1 |
| Karabelis, A | 1 |
| Vadiaka, M | 1 |
| Skopelitis, E | 1 |
| Kordossis, T | 1 |
| Tsavaris, N | 1 |
| Ropela, JA | 1 |
| van Die, L | 1 |
| Oyen, WJ | 1 |
| Rongen, GA | 1 |
| Friesen, C | 1 |
| Hill, I | 1 |
| Woods, C | 1 |
| Karthik, R | 1 |
| Carlson, JW | 1 |
| Fowler, JM | 1 |
| Saltzman, AK | 1 |
| Carter, JR | 1 |
| Chen, MD | 1 |
| Mitchell, SK | 1 |
| Dunn, D | 1 |
| Carson, LF | 1 |
| Adcock, LL | 1 |
| Twiggs, LB | 1 |
| Counsell, R | 1 |
| Pratt, J | 1 |
| Williams, MV | 1 |
| D'Antonio, D | 1 |
| Piccolomini, R | 1 |
| Iacone, A | 1 |
| Fioritoni, G | 1 |
| Parruti, G | 1 |
| Betti, S | 1 |
| Quaglietta, AM | 1 |
| Accorsi, P | 1 |
| Dell'Isola, M | 1 |
| Favalli, C | 1 |
| Gilbert, C | 1 |
| Meisenberg, B | 1 |
| Vredenburgh, J | 1 |
| Ross, M | 1 |
| Hussein, A | 1 |
| Perfect, J | 1 |
| Peters, WP | 1 |
| Rubenstein, EB | 2 |
| Benjamin, RS | 1 |
| Loewy, J | 1 |
| Escalante, C | 1 |
| Hughes, P | 1 |
| Moreland, B | 1 |
| Fender, A | 1 |
| Kennedy, K | 1 |
| Lo, WK | 1 |
| Dey, SK | 1 |
| Hidalgo, M | 2 |
| Hornedo, J | 2 |
| Lumbreras, C | 2 |
| Trigo, JM | 1 |
| Gómez, C | 1 |
| Perea, S | 2 |
| Ruiz, A | 1 |
| Hitt, R | 1 |
| Cortés-Funes, H | 2 |
| James, AH | 1 |
| Katz, VL | 1 |
| Dotters, DJ | 1 |
| Rogers, RG | 1 |
| Fischer, BP | 1 |
| Müller, A | 1 |
| Strauss, R | 1 |
| Schneider, HT | 1 |
| Hahn, EG | 1 |
| Marie, JP | 1 |
| Vekhoff, A | 1 |
| Pico, JL | 1 |
| Guy, H | 1 |
| Andremont, A | 1 |
| Richet, H | 1 |
| Griggs, JJ | 1 |
| Blair, EA | 1 |
| Norton, JR | 1 |
| Rowe, JM | 1 |
| Flesher, WR | 1 |
| Betts, RF | 1 |
| Beovic, B | 1 |
| Mrhar, A | 1 |
| Karba, R | 1 |
| Zupancic, T | 1 |
| Grabnar, I | 1 |
| Belic, A | 1 |
| Marolt-Gomiscek, M | 1 |
| Minotti, V | 1 |
| Gentile, G | 1 |
| Bucaneve, G | 1 |
| Iori, AP | 1 |
| Micozzi, A | 1 |
| Cavicchi, F | 1 |
| Barbabietola, G | 1 |
| Landonio, G | 1 |
| Menichetti, F | 1 |
| Martino, P | 1 |
| Del Favero, A | 1 |
| Schröder, CP | 1 |
| de Vries, EG | 1 |
| Mulder, NH | 1 |
| Willemse, PH | 1 |
| Sleijfer, DT | 1 |
| Hospers, GA | 1 |
| van der Graaf, WT | 1 |
| Petropoulos, D | 1 |
| Roberts, WM | 1 |
| Rytting, M | 1 |
| Zipf, T | 1 |
| Chan, KW | 1 |
| Culbert, SJ | 1 |
| Danielson, M | 1 |
| Jeha, SS | 1 |
| Kuttesch, JF | 1 |
| Freifeld, A | 1 |
| Marchigiani, D | 1 |
| Walsh, T | 1 |
| Chanock, S | 1 |
| Lewis, L | 1 |
| Hiemenz, J | 1 |
| Hiemenz, S | 1 |
| Hicks, JE | 1 |
| Gill, V | 1 |
| Steinberg, SM | 1 |
| Pizzo, PA | 1 |
| Langenaeken, J | 1 |
| Gaya, H | 2 |
| Antabli, BA | 1 |
| Bross, P | 1 |
| Siegel, RS | 1 |
| Small, CD | 1 |
| Tabbara, IA | 1 |
| Hakola, K | 1 |
| Savola, J | 1 |
| Yeh, SP | 1 |
| Hsueh, EJ | 1 |
| Yu, MS | 1 |
| Wu, H | 1 |
| Wang, YC | 1 |
| Petrilli, AS | 1 |
| Dantas, LS | 1 |
| Campos, MC | 1 |
| Tanaka, C | 1 |
| Ginani, VC | 1 |
| Seber, A | 1 |
| Gomez-Martin, C | 1 |
| Solá, C | 1 |
| Valentí, V | 1 |
| Arcediano, A | 1 |
| Rodriguez, M | 1 |
| Salazar, R | 1 |
| Marra, CA | 1 |
| Frighetto, L | 1 |
| Quaia, CB | 1 |
| de Lemos, ML | 1 |
| Warkentin, DI | 1 |
| Marra, F | 1 |
| Jewesson, PJ | 1 |
| Zikonov, I | 1 |
| Potasman, I | 1 |
| Giamarellou, H | 1 |
| Bassaris, HP | 1 |
| Petrikkos, G | 1 |
| Busch, W | 1 |
| Voulgarelis, M | 1 |
| Antoniadou, A | 1 |
| Grouzi, E | 1 |
| Zoumbos, N | 1 |
| Delarive, P | 1 |
| Baumgartner, JD | 1 |
| Glauser, MP | 1 |
| Rao, GS | 1 |
| Ramesh, S | 1 |
| Ahmad, AH | 1 |
| Tripathi, HC | 1 |
| Sharma, LD | 1 |
| Malik, JK | 1 |
| Rodriguez-Brieshcke, T | 1 |
| Firpo, V | 1 |
| Armada, A | 1 |
| Fernández, C | 1 |
| Cáceres, E | 1 |
| Slesak, G | 1 |
| Döller, PC | 1 |
| Mayer, TA | 1 |
| Bersoff-Matcha, S | 1 |
| Murphy, C | 1 |
| Earls, J | 1 |
| Harper, S | 1 |
| Pauze, D | 1 |
| Nguyen, M | 1 |
| Rosenthal, J | 1 |
| Cerva, D | 1 |
| Druckenbrod, G | 1 |
| Hanfling, D | 1 |
| Fatteh, N | 1 |
| Napoli, A | 1 |
| Nayyar, A | 1 |
| Berman, EL | 1 |
| Bunn, PA | 1 |
| Postmus, PE | 1 |
| Ardizzoni, A | 1 |
| Lee, DG | 1 |
| Choi, SM | 1 |
| Choi, JH | 1 |
| Yoo, JH | 1 |
| Park, YH | 1 |
| Kim, YJ | 1 |
| Lee, S | 1 |
| Min, CK | 1 |
| Kim, HJ | 1 |
| Kim, DW | 1 |
| Lee, JW | 1 |
| Min, WS | 1 |
| Shin, WS | 1 |
| Kim, CC | 1 |
| Kelsey, SM | 4 |
| Weinhardt, B | 1 |
| Collins, PW | 2 |
| Newland, AC | 4 |
| Johnson, PR | 2 |
| Liu Yin, JA | 1 |
| Tooth, JA | 2 |
| Samuelsson, J | 1 |
| Nilsson, PG | 1 |
| Wahlin, A | 1 |
| Lerner, R | 1 |
| Winqvist, I | 1 |
| Palmblad, J | 1 |
| Dhawan, A | 1 |
| Marwaha, RK | 1 |
| Drusano, GL | 1 |
| Hyatt, DS | 1 |
| Rogers, TR | 1 |
| McCarthy, DM | 1 |
| Samson, DS | 1 |
| Meunier, F | 1 |
| Zinner, SH | 1 |
| Klastersky, J | 1 |
| Glauser, M | 1 |
| Brouwer, WK | 1 |
| Hoogkamp-Korstanje, JA | 1 |
| Kuiper, KM | 1 |
| Delord, C | 1 |
| Weinhard, B | 1 |
| Lim, SH | 1 |
| Smith, MP | 1 |
| Goldstone, AH | 1 |
| Machin, SJ | 1 |
| Wood, ME | 2 |
| Shaw, E | 2 |
| Jenkins, GC | 1 |
| Yin, JA | 1 |
| Philpott-Howard, JN | 1 |
| Barker, KF | 1 |
| Wade, JJ | 1 |
| Kaczmarski, RS | 1 |
| Smedley, JC | 1 |
| Mufti, GJ | 1 |
| Chan, CC | 1 |
| Oppenheim, BA | 1 |
| Anderson, H | 1 |
| Swindell, R | 1 |
| Scarffe, JH | 1 |
| Bayston, KF | 1 |
| Want, S | 1 |
| Cohen, J | 1 |
| Flaherty, JP | 1 |
| Waitley, D | 1 |
| Edlin, B | 1 |
| George, D | 1 |
| Arnow, P | 1 |
| O'Keefe, P | 1 |
| Weinstein, RA | 1 |
| Pichler, H | 1 |
| Diridl, G | 1 |
| Wolf, D | 1 |
| Smith, GM | 2 |
| Leyland, MJ | 2 |
| Farrell, ID | 2 |
| Geddes, AM | 2 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Relevance of Biomarkers and Clinical Predictors of Outcome in Unselected Population With Febrile Urinary Tract Infection at Primary Care and Emergency Department in a Prospective, Randomized Cohort Trial Comparing Short (7 Days) Antibiotic Treatment With [NCT00809913] | Phase 4 | 200 participants (Actual) | Interventional | 2008-12-31 | Completed | ||
| A Prospective Multi-Center Study on Pediatric Patients With Fever in Severe Chemotherapy Induced Neutropenia, Including a Randomized Comparison of Outpatient Management and Oral Antimicrobial Therapy Versus Inpatient Management and Intravenous Antimicrobi[NCT00107081] | Phase 3 | 70 participants (Actual) | Interventional | 2004-01-31 | Terminated (stopped due to Accrual goal for interventional part not achievable) | ||
| Randomized Controlled Trial Comparing Ciprofloxacin With Cefepime in Febrile Neutropenic Patients With Hematologic Diseases[NCT00137787] | Phase 3 | 51 participants (Actual) | Interventional | 2005-04-30 | Completed | ||
| Oral Empirical Therapy of Fever in Low-Risk Neutropenic Cancer Patients: A Prospective, Double-Blind, Randomized, Multicenter Trial Comparing Monotherapy (Single Daily Dose Moxifloxacin) With Combination Therapy (Ciprofloxacin Plus Amoxicillin/Clavulanic [NCT00062231] | 351 participants (Actual) | Interventional | 2002-04-30 | Terminated (stopped due to low accrual) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
7 reviews available for ciprofloxacin and Pyrexia
| Article | Year |
|---|---|
Systematic review: the bioavailability of orally administered antibiotics during the initial phase of a systemic infection in non-ICU patients.
Topics: Administration, Oral; Anti-Bacterial Agents; Biological Availability; Ciprofloxacin; Fever; Humans; | 2021 |
[Treatment and prevention of infections in cancer patients with neutropenia].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Antineoplastic Agents; Bacterial In | 2011 |
Enterobius vermicularis infection of female genital tract: a report of three cases and review of literature.
Topics: Abdominal Pain; Adult; Ciprofloxacin; Enterobiasis; Fallopian Tube Diseases; Fallopian Tubes; Female | 2003 |
Ciprofloxacin in treatment of fever and neutropenia in pediatric cancer patients.
Topics: Ambulatory Care; Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Bacterial I | 2003 |
[Treatment with oral antibiotics of febrile neutropenia in onco-haematology. The experience of the EORTC antimicrobial group].
Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Bacterial Infections; Ceftazidi | 2004 |
Ciprofloxacin vs an aminoglycoside in combination with a beta-lactam for the treatment of febrile neutropenia: a meta-analysis of randomized controlled trials.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Drug Therapy, Combination; Feve | 2005 |
Ciprofloxacin-induced nephrotoxicity in patients with cancer.
Topics: Acute Kidney Injury; Aged; Ciprofloxacin; Female; Fever; Humans; Kidney; Male; Middle Aged; Neoplasm | 1993 |
60 trials available for ciprofloxacin and Pyrexia
| Article | Year |
|---|---|
Fosfomycin Vs Ciprofloxacin as Oral Step-Down Treatment for Escherichia coli Febrile Urinary Tract Infections in Women: A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial.
Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; COVID-19; Double-Blind Method; Escherichia coli; Escher | 2022 |
A single dose of ciprofloxacin reduces the duration of diarrhea among service members deployed in Africa.
Topics: Africa; Anti-Bacterial Agents; Ciprofloxacin; Diarrhea; Fever; Humans | 2023 |
Treatment duration of febrile urinary tract infection: a pragmatic randomized, double-blind, placebo-controlled non-inferiority trial in men and women.
Topics: Adult; Aged; Anti-Bacterial Agents; Ciprofloxacin; Double-Blind Method; Drug Administration Schedule | 2017 |
Chemoprophylaxis during transrectal prostate needle biopsy: critical analysis through randomized clinical trial.
Topics: Adenocarcinoma; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Biopsy, Large-Core Needle; Bloo | 2018 |
Oral fosfomycin versus ciprofloxacin in women with E.coli febrile urinary tract infection, a double-blind placebo-controlled randomized controlled non-inferiority trial (FORECAST).
Topics: Administration, Intravenous; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti- | 2018 |
Single-dose versus multiple-dose ciprofloxacin plus metronidazole prophylaxis in transrectal ultrasound-guided biopsy of the prostate: a randomized controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Bacterial | 2014 |
A prospective, controlled, randomized, non-blind, comparative study of the efficacy and safety of a once daily high dose of ceftriaxone plus ciprofloxacin versus thrice daily ceftazidime plus amikacin in empirical therapy for febrile neutropenic patients.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Ceftazidime; Ceftriaxo | 2008 |
Treatment duration of febrile urinary tract infection (FUTIRST trial): a randomized placebo-controlled multicenter trial comparing short (7 days) antibiotic treatment with conventional treatment (14 days).
Topics: Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Double-Blind Method; Female; Fever; Gentamicins; | 2009 |
Prophylactic antibiotics for the prevention of neutropenic fever in patients undergoing autologous stem-cell transplantation: results of a single institution, randomized phase 2 trial.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Ciprofloxacin; Fever; Graft Survival; Hematologic Neo | 2010 |
Infectious complications and hospital admissions after prostate biopsy in a European randomized trial.
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Biopsy, Needle; Chi-Squar | 2012 |
First-day step-down to oral outpatient treatment versus continued standard treatment in children with cancer and low-risk fever in neutropenia. A randomized controlled trial within the multicenter SPOG 2003 FN study.
Topics: Administration, Oral; Adolescent; Ambulatory Care; Amoxicillin; Anti-Bacterial Agents; Antineoplasti | 2012 |
Ciprofloxacin reduces occurrence of fever in children with acute leukemia who develop neutropenia during chemotherapy.
Topics: Administration, Oral; Adolescent; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineoplastic Agen | 2013 |
Randomized controlled trial comparing ciprofloxacin and cefepime in febrile neutropenic patients with hematological malignancies.
Topics: Adolescent; Adult; Aged; Algorithms; Anti-Bacterial Agents; Cefepime; Cephalosporins; Ciprofloxacin; | 2013 |
Oral antibiotics for fever in low-risk neutropenic patients with cancer: a double-blind, randomized, multicenter trial comparing single daily moxifloxacin with twice daily ciprofloxacin plus amoxicillin/clavulanic acid combination therapy--EORTC infectiou
Topics: Administration, Oral; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Ag | 2013 |
Antibiotic rotation for febrile neutropenic patients with hematological malignancies: clinical significance of antibiotic heterogeneity.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Cefepime; | 2013 |
Ciprofloxacin plus piperacillin compared with tobramycin plus piperacillin as empirical therapy in febrile neutropenic patients. A randomized, double-blind trial.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Bone Marrow Transplant | 2002 |
Ciprofloxacin and amoxicillin as continuation treatment of febrile neutropenia in pediatric cancer patients.
Topics: Administration, Oral; Ambulatory Care; Amoxicillin; Antineoplastic Agents; Blood Cell Count; Child; | 2003 |
[Antibacterial prophylaxis of bacteriuria at transrectal multifocal prostatic biopsy].
Topics: Administration, Topical; Anti-Infective Agents; Anti-Infective Agents, Local; Antibiotic Prophylaxis | 2002 |
Outpatient, sequential, parenteral-oral antibiotic therapy for lower risk febrile neutropenia in children with malignant disease: a single-center, randomized, controlled trial in Argentina.
Topics: Administration, Oral; Adolescent; Ambulatory Care; Amikacin; Anti-Bacterial Agents; Antineoplastic A | 2003 |
Ciprofloxacin for 2 or 4 weeks in the treatment of febrile urinary tract infection in men: a randomized trial with a 1 year follow-up.
Topics: Administration, Oral; Adult; Aged; Ciprofloxacin; Confidence Intervals; Dose-Response Relationship, | 2003 |
Piperacillin-tazobactam versus ciprofloxacin plus amoxicillin in the treatment of infective episodes after liver transplantation.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bacterial Infections; Ciprofloxacin; Do | 2003 |
Randomized trial of oral versus intravenous antibiotics in low-risk febrile neutropenic patients with lung cancer.
Topics: Administration, Oral; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Ce | 2004 |
Outcomes of treatment pathways in outpatient treatment of low risk febrile neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Ampicillin; Anti-Bacterial Agents; Cancer Care Facilities; | 2004 |
Prevention of chemotherapy-induced febrile neutropenia by prophylactic antibiotics plus or minus granulocyte colony-stimulating factor in small-cell lung cancer: a Dutch Randomized Phase III Study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; Antineoplastic Combin | 2005 |
Efficacy of intravenous ciprofloxacin in patients with febrile neutropenia refractory to initial therapy.
Topics: Adult; Aged; Algorithms; Carbapenems; Cefepime; Cephalosporins; Ciprofloxacin; Female; Fever; Hemato | 2006 |
Levofloxacin vs. ciprofloxacin plus phenethicillin for the prevention of bacterial infections in patients with haematological malignancies.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Ciprofloxacin; Cross Infecti | 2007 |
Comparison of ciprofloxacin, ofloxacin and pefloxacin for the prevention of the bacterial infection in neutropenic patients with haematological malignancies.
Topics: Adult; Aged; Agranulocytosis; Anti-Infective Agents; Bacteremia; Bacterial Infections; Ciprofloxacin | 1994 |
Sequential prophylactic oral and empiric once-daily parenteral antibiotics for neutropenia and fever after high-dose chemotherapy and autologous bone marrow support.
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; B | 1994 |
Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer.
Topics: Administration, Oral; Adolescent; Adult; Aged; Ambulatory Care; Aztreonam; Bacteremia; Bacterial Inf | 1993 |
Lack of ability of ciprofloxacin-rifampin prophylaxis to decrease infection-related morbidity in neutropenic patients given cytotoxic therapy and peripheral blood stem cell transplants.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antineoplastic Com | 1997 |
Neutropenic infections: a review of the French Febrile Aplasia Study Group trials in 608 febrile neutropenic patients.
Topics: Amikacin; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Therapy, Combinati | 1998 |
Ciprofloxacin plus piperacillin is an equally effective regimen for empiric therapy in febrile neutropenic patients compared with standard therapy.
Topics: Adult; Amphotericin B; Bacterial Infections; Ciprofloxacin; Drug Therapy, Combination; Female; Fever | 1998 |
Domiciliary treatment of febrile episodes in cancer patients: a prospective randomized trial comparing oral versus parenteral empirical antibiotic treatment.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacterial Infections; C | 1999 |
Prevention of febrile leucopenia after chemotherapy in high-risk breast cancer patients: no significant difference between granulocyte-colony stimulating growth factor or ciprofloxacin plus amphotericin B.
Topics: Adult; Amphotericin B; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Ciprofloxac | 1999 |
Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients.
Topics: Adolescent; Ambulatory Care; Antineoplastic Agents; Bacterial Infections; Ceftazidime; Cephalosporin | 1999 |
A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy.
Topics: Administration, Oral; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Antineoplastic Ag | 1999 |
Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy. International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Can
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Agranulocytosis; Amikacin; Amoxici | 1999 |
Empiric antimicrobial therapy of febrile neutropenic patients undergoing haematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Bacterial Infections; Bone Marrow Transplantation; C | 1999 |
Oral ciprofloxacin vs. intravenous ceftriaxone administered in an outpatient setting for fever and neutropenia in low-risk pediatric oncology patients: randomized prospective trial.
Topics: Administration, Oral; Adolescent; Adult; Ambulatory Care; Anti-Infective Agents; Antineoplastic Agen | 2000 |
Rifampin does not improve the efficacy of quinolone antibacterial prophylaxis in neutropenic cancer patients: results of a randomized clinical trial.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antineoplastic Age | 2000 |
A new ciprofloxacin stepdown program in the treatment of high-risk febrile neutropenia: a clinical and economic analysis.
Topics: Administration, Oral; Adult; Anti-Infective Agents; Ciprofloxacin; Costs and Cost Analysis; Female; | 2000 |
Monotherapy with intravenous followed by oral high-dose ciprofloxacin versus combination therapy with ceftazidime plus amikacin as initial empiric therapy for granulocytopenic patients with fever.
Topics: Administration, Oral; Agranulocytosis; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Cefta | 2000 |
Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia.
Topics: Administration, Oral; Adolescent; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antineopla | 2001 |
Selective bowel decontamination for the prevention of infection in acute myelogenous leukemia: a prospective randomized trial.
Topics: Adult; Anti-Infective Agents; Antibiotic Prophylaxis; Bacterial Infections; Ciprofloxacin; Drug Ther | 2002 |
Teicoplanin plus ciprofloxacin versus gentamicin plus piperacillin in the treatment of febrile neutropenic patients.
Topics: Bacterial Infections; Ciprofloxacin; Drug Therapy, Combination; Fever; Gentamicins; Glycopeptides; H | 1992 |
A randomized trial of high-dose ciprofloxacin versus azlocillin and netilmicin in the empirical therapy of febrile neutropenic patients.
Topics: Adolescent; Adult; Aged; Azlocillin; Ciprofloxacin; Double-Blind Method; Drug Therapy, Combination; | 1992 |
A randomized trial of ciprofloxacin plus azlocillin versus netilmicin plus azlocillin for the empirical treatment of fever in neutropenic patients.
Topics: Azlocillin; Ciprofloxacin; Drug Therapy, Combination; Fever; Gram-Negative Bacterial Infections; Gra | 1991 |
Prospective randomized evaluation of ciprofloxacin versus piperacillin plus amikacin for empiric antibiotic therapy of febrile granulocytopenic cancer patients with lymphomas and solid tumors. The European Organization for Research on Treatment of Cancer
Topics: Adult; Aged; Aged, 80 and over; Agranulocytosis; Amikacin; Bacterial Infections; Ciprofloxacin; Drug | 1991 |
Prevention of bacterial infection in neutropenic patients with hematologic malignancies. A randomized, multicenter trial comparing norfloxacin with ciprofloxacin. The GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Ciprofloxacin; Female; Fever; | 1991 |
Antibiotic prophylaxis in vaginal hysterectomy. Three doses of cefuroxime plus metronidazole versus one dose of ciprofloxacin.
Topics: Adult; Aged; Aged, 80 and over; Cefuroxime; Ciprofloxacin; Drug Administration Schedule; Drug Therap | 1990 |
A randomized study of teicoplanin plus ciprofloxacin versus gentamicin plus piperacillin for the empirical treatment of fever in neutropenic patients.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bone Marrow Transplantation; Ciprofloxacin; D | 1990 |
A randomized prospective study of ceftazidime and ciprofloxacin with or without teicoplanin as an empiric antibiotic regimen for febrile neutropenic patients.
Topics: Anti-Bacterial Agents; Bacteria; Catheterization, Peripheral; Ceftazidime; Ciprofloxacin; Drug Thera | 1990 |
A comparative study of intravenous ciprofloxacin and benzylpenicillin versus netilmicin and piperacillin for the empirical treatment of fever in neutropenic patients.
Topics: Adult; Bacterial Infections; Ciprofloxacin; Drug Therapy, Combination; Fever; Humans; Injections, In | 1990 |
High dose intravenous ciprofloxacin in febrile neutropenic patients.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Ciprofloxacin; Female; Fever; Gram-Negative Bacteria; | 1990 |
Randomized multicentre study of ciprofloxacin and azlocillin versus gentamicin and azlocillin in the treatment of febrile neutropenic patients.
Topics: Adolescent; Adult; Azlocillin; Bacterial Infections; Ciprofloxacin; Drug Therapy, Combination; Femal | 1990 |
Intravenous ciprofloxacin as empirical treatment of febrile neutropenic patients.
Topics: Adult; Agranulocytosis; Bacteria; Bacterial Infections; Ciprofloxacin; Drug Therapy, Combination; Fe | 1989 |
Randomized trial comparing ciprofloxacin plus netilmicin versus piperacillin plus netilmicin for empiric treatment of fever in neutropenic patients.
Topics: Administration, Oral; Adolescent; Adult; Aged; Agranulocytosis; Bacterial Infections; Bone Marrow Tr | 1989 |
A prospective, randomized comparison of ceftazidime and ciprofloxacin as initial empiric therapy in neutropenic patients with fever.
Topics: Adolescent; Adult; Agranulocytosis; Bacterial Infections; Ceftazidime; Ciprofloxacin; Female; Fever; | 1989 |
Multicenter, randomized trial of ciprofloxacin plus azlocillin versus ceftazidime plus amikacin for empiric treatment of febrile neutropenic patients.
Topics: Adult; Aged; Aged, 80 and over; Agranulocytosis; Amikacin; Azlocillin; Bacterial Infections; Ceftazi | 1989 |
Ciprofloxacin in the treatment of acute bacterial diarrhea: a double blind study.
Topics: Acute Disease; Adult; Aged; Anti-Bacterial Agents; Campylobacter fetus; Campylobacter Infections; Ci | 1986 |
63 other studies available for ciprofloxacin and Pyrexia
| Article | Year |
|---|---|
Relay oral therapy in febrile urinary tract infections caused by extended spectrum beta-lactamase-producing Enterobacteriaceae in children: A French multicenter study.
Topics: Administration, Oral; Adolescent; Amoxicillin-Potassium Clavulanate Combination; beta-Lactamases; Ce | 2021 |
The effect of the acute phase of infection on absorption of and exposure to orally administered antibiotics in non-critically ill, hospitalized patients.
Topics: Amoxicillin; Anti-Bacterial Agents; Ciprofloxacin; Fever; Humans | 2023 |
The effect of the acute phase of infection on absorption of and exposure to orally administered antibiotics in non-critically ill, hospitalized patients.
Topics: Amoxicillin; Anti-Bacterial Agents; Ciprofloxacin; Fever; Humans | 2023 |
The effect of the acute phase of infection on absorption of and exposure to orally administered antibiotics in non-critically ill, hospitalized patients.
Topics: Amoxicillin; Anti-Bacterial Agents; Ciprofloxacin; Fever; Humans | 2023 |
The effect of the acute phase of infection on absorption of and exposure to orally administered antibiotics in non-critically ill, hospitalized patients.
Topics: Amoxicillin; Anti-Bacterial Agents; Ciprofloxacin; Fever; Humans | 2023 |
The effect of the acute phase of infection on absorption of and exposure to orally administered antibiotics in non-critically ill, hospitalized patients.
Topics: Amoxicillin; Anti-Bacterial Agents; Ciprofloxacin; Fever; Humans | 2023 |
The effect of the acute phase of infection on absorption of and exposure to orally administered antibiotics in non-critically ill, hospitalized patients.
Topics: Amoxicillin; Anti-Bacterial Agents; Ciprofloxacin; Fever; Humans | 2023 |
The effect of the acute phase of infection on absorption of and exposure to orally administered antibiotics in non-critically ill, hospitalized patients.
Topics: Amoxicillin; Anti-Bacterial Agents; Ciprofloxacin; Fever; Humans | 2023 |
The effect of the acute phase of infection on absorption of and exposure to orally administered antibiotics in non-critically ill, hospitalized patients.
Topics: Amoxicillin; Anti-Bacterial Agents; Ciprofloxacin; Fever; Humans | 2023 |
The effect of the acute phase of infection on absorption of and exposure to orally administered antibiotics in non-critically ill, hospitalized patients.
Topics: Amoxicillin; Anti-Bacterial Agents; Ciprofloxacin; Fever; Humans | 2023 |
Acute hepatitis and pancytopenia related to non-typhoidal salmonella infection in a human immunodeficiency virus-infected patient.
Topics: Acute Disease; Anti-Bacterial Agents; Antiretroviral Therapy, Highly Active; Ciprofloxacin; Fatigue; | 2019 |
Atypical presentation of Middle East respiratory syndrome coronavirus in a Lebanese patient returning from Saudi Arabia.
Topics: Adult; Ciprofloxacin; Coronavirus Infections; Fatigue; Fever; Humans; Lebanon; Male; Middle East Res | 2018 |
Francisella tularensis as the cause of protracted fever.
Topics: Abdominal Pain; Anti-Bacterial Agents; Body Weight; Ceftriaxone; Ciprofloxacin; Cough; Diagnosis, Di | 2020 |
Severe infection with multidrug-resistant
Topics: Adult; Anti-Infective Agents; beta-Lactamases; Cholangiopancreatography, Endoscopic Retrograde; Chol | 2017 |
Invasive meningococcal disease due to ciprofloxacin-resistant Neisseria meningitidis sequence type 4821: The first case in Japan.
Topics: Anti-Bacterial Agents; Ceftriaxone; Child, Preschool; Ciprofloxacin; Diagnostic Tests, Routine; Drug | 2018 |
Investigation of a typhoid fever epidemic in Moyale Sub-County, Kenya, 2014-2015.
Topics: Abdominal Pain; Adolescent; Adult; Anti-Bacterial Agents; Cephalosporins; Child; Ciprofloxacin; Comm | 2018 |
[Fever and lymphadenopathy. Report of 4 cases of tularemia].
Topics: Aged; Anti-Infective Agents; Child; Ciprofloxacin; Female; Fever; Gentamicins; Humans; Lymphatic Dis | 2013 |
Ciprofloxacin prophylaxis in children with acute leukemia in an era of increasing antibiotic resistance.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Ciprofloxacin; Female; Fever; Humans; Male; Neutropeni | 2013 |
Bacteremia due to Aeromonas hydrophila in acute lymphoblastic leukemia.
Topics: Acute Disease; Aeromonas hydrophila; Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Female; Fever | 2013 |
Prophylaxis of neutropenic fever with ciprofloxacin in patients with acute myeloid leukemia treated with intensive chemotherapy.
Topics: Adolescent; Aged; Antibiotic Prophylaxis; Ciprofloxacin; Female; Fever; Humans; Incidence; Induction | 2016 |
Hepatic cyst infection following aspiration sclerotherapy: a case series.
Topics: Abdominal Pain; Aged; Anti-Bacterial Agents; Bacterial Infections; Ciprofloxacin; Cross Infection; C | 2014 |
Comparison of antibiotic prophylaxis with cotrimoxazole/colistin (COT/COL) versus ciprofloxacin (CIP) in patients with acute myeloid leukemia.
Topics: Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineoplastic Agents; Bacterial Infecti | 2015 |
Interactive medical case. A Liberian health care worker with fever.
Topics: Anti-Bacterial Agents; Antibodies, Viral; Ciprofloxacin; Combined Modality Therapy; Diagnosis, Diffe | 2015 |
CLINICAL PROBLEM-SOLVING. Back to Nature.
Topics: Adult; Anorexia; Anti-Bacterial Agents; Ciprofloxacin; Colitis, Ulcerative; Diagnosis, Differential; | 2015 |
Role of age and sex in determining antibiotic resistance in febrile urinary tract infections.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combinati | 2016 |
Effect of induced pyrexia on the disposition kinetics of ciprofloxacin in dogs.
Topics: Animals; Anti-Infective Agents; Body Temperature; Chromatography, High Pressure Liquid; Ciprofloxaci | 2009 |
Incidence of vancomycin-resistant enterococci (VRE) infection in high-risk febrile neutropenic patients colonized with VRE.
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Case-Control Studies; Ciprofloxacin; Daptomycin; Ente | 2010 |
Guardian ad litem, a potentially expensive invitation to either the mismanagement or management of patients with cognitive disorders.
Topics: Aged; Catheters; Ciprofloxacin; Cognition Disorders; Cystostomy; Elder Abuse; Fever; Humans; Legal G | 2010 |
Occurrence & antibiogram of Salmonella Typhi & S. Paratyphi A isolated from Rourkela, Orissa.
Topics: Anti-Bacterial Agents; Cephalosporins; Ciprofloxacin; Community-Acquired Infections; Drug Resistance | 2011 |
Effect of biofilm formation on the excretion of Salmonella enterica serovar Typhi in feces.
Topics: Adolescent; Adult; Anti-Infective Agents; Bacterial Proteins; Bacterial Shedding; Biofilms; Caco-2 C | 2011 |
A 60-year-old man from the highlands of Peru with fever and hemolysis.
Topics: Anemia; Bartonella bacilliformis; Bartonella Infections; Ceftriaxone; Ciprofloxacin; Fever; Hemolysi | 2012 |
"Good enough" medicine: noninferiority clinical trials and the management of fever and neutropenia.
Topics: Ambulatory Care; Amoxicillin; Anti-Bacterial Agents; Ciprofloxacin; Drug Therapy, Combination; Femal | 2012 |
Cutaneous abscess leading to sepsis by Aeromonas hydrophila.
Topics: Abscess; Aeromonas hydrophila; Cefepime; Cephalosporins; Ciprofloxacin; Fever; Gram-Negative Bacteri | 2013 |
Infected simple renal cyst. Case report.
Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; Ciprofloxacin; Female; Fever; Humans; Kidney Dis | 2012 |
Outpatient therapy for fever and neutropenia is safe but implementation is the key.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Female; Fev | 2013 |
Summaries for patients. Treatment of fever in hospitalized patients with low white blood cell counts.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Bone Marrow Transplant | 2002 |
The efficacy of prophylactic outpatient antibiotics for the prevention of neutropenic fever associated with high-dose etoposide (VP-16) for stem cell mobilization.
Topics: Ambulatory Care; Antibiotic Prophylaxis; Cefepime; Cephalosporins; Ciprofloxacin; Clarithromycin; Da | 2002 |
Ciprofloxacin versus tobramycin for neutropenic fevers.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Therapy, Combination; Fever; Human | 2003 |
Ciprofloxacin versus tobramycin for neutropenic fevers.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Therapy, Combination; Fever; Human | 2003 |
[Salmonella aortitis. A rare cause of fever and backache].
Topics: Anti-Infective Agents; Aorta, Abdominal; Aortitis; Back Pain; Blood Vessel Prosthesis Implantation; | 2005 |
Infections of febrile neutropenic patients in malignant hematological diseases (second study period).
Topics: Antibiotic Prophylaxis; Antineoplastic Agents; Bacteremia; Bacterial Infections; Ciprofloxacin; Fema | 2005 |
Systematic reviews and meta-analysis of febrile neutropenia.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Drug Therapy, Combination; Feve | 2005 |
A rare cause of sepsis in an 18 year old. Lemierre's syndrome with external jugular vein thrombosis.
Topics: Adolescent; Anti-Infective Agents; Body Piercing; Ciprofloxacin; Clindamycin; Diagnosis, Differentia | 2006 |
The outpatient management of low-risk febrile patients with neutropenia: risk assessment over the telephone.
Topics: Adult; Aged; Ambulatory Care; Anti-Infective Agents; Antineoplastic Combined Chemotherapy Protocols; | 2007 |
Case report: parotid abscess due to Salmonella enterica serovar Enteritidis in an immunocompetent adult.
Topics: Abscess; Anti-Bacterial Agents; Ciprofloxacin; Fever; Humans; Male; Middle Aged; Pain; Parotid Disea | 2007 |
Anthrax meningoencephalitis successfully treated.
Topics: Aged; Anthrax; Anti-Bacterial Agents; Bacillus anthracis; Brain Edema; Cefoperazone; Cerebrospinal F | 2007 |
Comparison of two oral regimens for the outpatient treatment of low-risk cancer patients with chemotherapy-induced neutropenia and fever: ciprofloxacin plus cefuroxime axetil versus ciprofloxacin plus amoxicillin/clavulanate.
Topics: Administration, Oral; Adult; Aged; Ambulatory Care; Amoxicillin-Potassium Clavulanate Combination; A | 2007 |
Fever and cough in a patient with diabetes. Empyema caused by S. typhimurium.
Topics: Aged; Anemia; Atrial Fibrillation; Ciprofloxacin; Comorbidity; Coronary Artery Disease; Cough; Diabe | 2007 |
Salmonella gastroenteritis mimicking onset of inflammatory bowel disease in children.
Topics: Abdominal Pain; Anti-Infective Agents; Child; Child, Preschool; Ciprofloxacin; Colonoscopy; Diagnosi | 2008 |
Infectious causes of macrophage activation syndrome.
Topics: Adolescent; Anti-Infective Agents; Bone Marrow; Ceftriaxone; Ciprofloxacin; Female; Fever; Humans; L | 2007 |
Chemoprophylaxis with oral ciprofloxacin in ovarian cancer patients receiving taxol.
Topics: Administration, Oral; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bacteria | 1994 |
Chemotherapy for germ cell tumours: prophylactic ciprofloxacin reduces the incidence of neutropenic fever.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Carbo | 1994 |
Nightmare due to ciprofloxacin in young patients.
Topics: Anti-Infective Agents; Child, Preschool; Ciprofloxacin; Female; Fever; Humans; Male; Sleep Wake Diso | 1995 |
Clostridium difficile infection in obstetric and gynecologic patients.
Topics: Abdominal Pain; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Bacterial Toxins; | 1997 |
[Tsutsugamushi fever. Rare rickettsiosis after a stay in the Philippines].
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bacterial; Ciprofloxacin; Clarithro | 1998 |
Influence of fever on the pharmacokinetics of ciprofloxacin.
Topics: Adult; Aged; Anti-Infective Agents; Ciprofloxacin; Female; Fever; Humans; Male; Middle Aged; Pyelone | 1999 |
[Meningitis caused by Francisella Tularensis].
Topics: Ciprofloxacin; Drug Therapy, Combination; Female; Fever; Follow-Up Studies; Francisella tularensis; | 1996 |
Oral ciprofloxacin as antibacterial prophylaxis after allogeneic bone marrow transplantation: a reappraisal.
Topics: Administration, Oral; Adolescent; Adult; Anti-Infective Agents; Bone Marrow Transplantation; Ciprofl | 1999 |
[Monocytic ehrlichiosis--an emerging zoonotic disease in Israel].
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Ehrlichia chaffeensis; Ehrlichiosis; Fever; Humans; I | 1999 |
[Evaluation of antibiotic prophylaxis in neutropenic patients with hematologic malignancies].
Topics: Adult; Aged; Antibiotic Prophylaxis; Antineoplastic Agents; Bacterial Infections; Ciprofloxacin; Dru | 2000 |
Effects of endotoxin-induced fever and probenecid on disposition of enrofloxacin and its metabolite ciprofloxacin after intravascular administration of enrofloxacin in goats.
Topics: Animals; Anti-Infective Agents; Area Under Curve; Ciprofloxacin; Drug Interactions; Endotoxins; Enro | 2000 |
[Fever and calf tenderness after travel in Thailand: murine typhus and deep vein thrombosis].
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Dehydration; Fever; Fibrinolytic Agents; Germany; Hepar | 2001 |
Clinical presentation of inhalational anthrax following bioterrorism exposure: report of 2 surviving patients.
Topics: Anthrax; Anti-Bacterial Agents; Bacillus anthracis; Bioterrorism; Blood; Ciprofloxacin; Clindamycin; | 2001 |
Editorial comments on 'Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: an EORTC double-blind placebo-controlled phase III study'.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Antineoplastic Combined Chemot | 2001 |
Assessment and treatment of low-risk febrile neutropenic (LRFN) pediatric patients with cancer.
Topics: Anti-Infective Agents; Ceftriaxone; Cephalosporins; Child; Ciprofloxacin; Fever; Humans; Neoplasms; | 2002 |
Reply to the article "Editorial comments on 'reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: an EORTC double-blind placebo-controlled phase III study'", by P.
Topics: Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cipro | 2002 |
A pilot study of piperacillin and ciprofloxacin as initial therapy for fever in severely neutropenic leukemia patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Ciprofloxacin; Drug Therapy, Combination; Dru | 1992 |
Acute glomerulonephritis in multi-drug resistant Salmonella typhi infection.
Topics: Blood Chemical Analysis; Child; Ciprofloxacin; Fever; Glomerulonephritis; Humans; Male; Peritoneal D | 1992 |
Optimal sampling theory and population modelling: application to determination of the influence of the microgravity environment on drug distribution and elimination.
Topics: Bayes Theorem; Ceftazidime; Chromatography, High Pressure Liquid; Ciprofloxacin; Cystic Fibrosis; Fe | 1991 |
A clinical, microbiological and pharmacokinetic study of ciprofloxacin plus vancomycin as initial therapy of febrile episodes in neutropenic patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Ciprofloxacin; Drug Therapy, Combination; Fever; Humans; L | 1988 |
Preliminary evaluation of ciprofloxacin, a new 4-quinolone antibiotic, in the treatment of febrile neutropenic patients.
Topics: Adult; Aged; Agranulocytosis; Bacterial Infections; Ciprofloxacin; Female; Fever; Half-Life; Humans; | 1986 |